相关实验视频
Updated: May 28, 2025
![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
05:15
Solid-phase Synthesis of [4.4] Spirocyclic Oximes
Published on: February 6, 2019
6.8K
螺旋环化合物作为药物化学家在药物发现中的创新工具
Marina T Varela1, Gleiston G Dias1, Luiz Fernando N de Oliveira1
1Universidade Estadual de Campinas (UNICAMP), Instituto de Química, Rua Monteiro Lobato 270, 13083-862, Campinas, Brazil.
European journal of medicinal chemistry
|February 14, 2025
概括
螺旋环化合物越来越多地用于药物发现,以改善药物的特性. 它们独特的结构增强了效力,选择性和药理动力学,使它们对药物化学家有价值.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药物发现 药物发现 药物发现
背景情况:
- 在临床候选药物和已批准的药物中,螺旋环形图案越来越普遍.
- 螺旋环的sp3丰富性质增强了生物活性化合物中类似药物的特性.
- 合成方法的进步使得药物化学家更容易获得螺旋环.
研究的目的:
- 审查螺旋环的化学成分,并强调主要的制备策略.
- 为了证明螺旋环在应对药物发现挑战中的实用性.
- 展示螺旋环在增强药物效能,选择性和药物动力学特征方面的作用.
主要方法:
- 对过去五年的出版物进行文献综述.
- 分析用于螺旋环制备的合成方法.
- 评估螺旋环对结构-活性关系 (SAR) 和药物特性的影响.
主要成果:
- 螺旋环为改善目标结合提供了形状限制.
- 引入螺旋环有效调节物理化学和药物动力学特性.
- 最近的文献证实了螺旋环作为一种提高功效和选择性的策略.
结论:
- 螺旋环是一种多功能支架,用于改善多种类似药物的特性.
- 螺旋环的可访问性和合成策略支持它们在药物化学中的更广泛应用.
- 螺旋循环代表了优化药物候选人在发现管道中的一个有价值的方法.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Cycloaddition Reactions: Overview
2.5K
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
2.5K
Structure-Activity Relationships and Drug Design
488
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
488
Pericyclic Reactions: Introduction
8.2K
Pericyclic reactions are organic reactions that occur via a concerted mechanism without generating any intermediates. The reactions proceed through the movement of electrons in a closed loop to form a cyclic transition state, where rearrangement of the σ and π bonds yields specific products.
Pericyclic reactions can be classified into three categories: electrocyclic reactions, cycloaddition reactions, and sigmatropic rearrangements. Electrocyclic reactions and sigmatropic...
Pericyclic reactions can be classified into three categories: electrocyclic reactions, cycloaddition reactions, and sigmatropic rearrangements. Electrocyclic reactions and sigmatropic...
8.2K
Stereoisomerism of Cyclic Compounds
8.7K
In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
8.7K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K

